Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghna Jani

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Age and Ageing|July 11, 2009
Unilateral breast oedema in a case of non-rheumatic giant left atriumMeghna Jani, Chandan Biswas
Expert Review of Clinical Immunology|March 7, 2012
Abatacept in the long-term treatment of rheumatoid arthritisMeghna Jani, Kimme L Hyrich
BMJ (Clinical Research Ed.)|December 8, 2017
Opioids are not just an American problemMeghna Jani, William G Dixon
The Journal of Pediatrics|October 18, 2005
Annual increase in body mass index in children with asthma on higher doses of inhaled steroidsMeghna Jani, Simon Ogston, Somnath Mukhopadhyay
Clinical Therapeutics|June 15, 2019
Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid ArthritisRuth Costello, Trixy David, Meghna Jani
Current Opinion in Rheumatology|February 22, 2019
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?Meghna Jani, Anne Barton, Kimme Hyrich
RMD Open|July 27, 2024
Is there a role for novel supplements in the management of fatigue in rheumatic diseases?Thomas Khoo, Meghna Jani, Hector Chinoy
Current Rheumatology Reports|May 19, 2015
Pharmacogenetics of treatment response in psoriatic arthritisMeghna Jani, Anne Barton, Pauline Ho
The Journal of Rheumatology|August 3, 2019
Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASSMeghna Jani, Hector Chinoy, Anne Barton, et al.
Rheumatology (Oxford, England)|January 12, 2018
Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so farMeghna Jani, William G Dixon, Hector Chinoy
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Age and Ageing|July 11, 2009
Unilateral breast oedema in a case of non-rheumatic giant left atriumMeghna Jani, Chandan Biswas
Expert Review of Clinical Immunology|March 7, 2012
Abatacept in the long-term treatment of rheumatoid arthritisMeghna Jani, Kimme L Hyrich
BMJ (Clinical Research Ed.)|December 8, 2017
Opioids are not just an American problemMeghna Jani, William G Dixon
The Journal of Pediatrics|October 18, 2005
Annual increase in body mass index in children with asthma on higher doses of inhaled steroidsMeghna Jani, Simon Ogston, Somnath Mukhopadhyay
Clinical Therapeutics|June 15, 2019
Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid ArthritisRuth Costello, Trixy David, Meghna Jani
Current Opinion in Rheumatology|February 22, 2019
Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?Meghna Jani, Anne Barton, Kimme Hyrich
RMD Open|July 27, 2024
Is there a role for novel supplements in the management of fatigue in rheumatic diseases?Thomas Khoo, Meghna Jani, Hector Chinoy
Current Rheumatology Reports|May 19, 2015
Pharmacogenetics of treatment response in psoriatic arthritisMeghna Jani, Anne Barton, Pauline Ho
The Journal of Rheumatology|August 3, 2019
Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASSMeghna Jani, Hector Chinoy, Anne Barton, et al.
Rheumatology (Oxford, England)|January 12, 2018
Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so farMeghna Jani, William G Dixon, Hector Chinoy
Pageof 8